Brian Morfitt is a General Partner with Frazier Healthcare Partners. Since joining the firm in 2003, he has been involved in Frazier’s investments in Bravo Health (acquired by Health Spring) CHG Healthcare Services (acquired by J.W.Childs Associates), Pentec Health (acquired by NEP), Priority Solutions (acquired by Thermo Fisher Scientific), and TridentUSA Health Services (acquired by Formation Capital). He also leads the Growth Buyout team’s debt capital markets activities.
In addition to HOPCo, Mr. Morfitt serves on the boards of Correct Care Solutions, Orthotic Holdings, Leiter’s, Matrix Medical Network, Southside Pharmacy, and the Health Care Private Equity Association.
James Waskovich is the Founder and Managing Partner of Princeton Ventures, a private equity firm that provides capital and expertise to rapidly growing, market-defining businesses in the consumer, healthcare and technology industries.
Mr. Waskovich was previously with ABS Capital Partners, where he worked with several of the firm’s investments including Cyveillance, DrugMax, eFashion Solutions, Emptoris, and RLX Technologies. Prior to that, he was responsible for sourcing and executing investments at Summit Partners. Mr. Waskovich received his B.A. from Washington and Lee University where he was a George Washington Honor Scholar.
In addition to HOPCo, Mr. Waskovich has participated on a number of boards including Double-Take Software, European Wax Center, Massage Envy, and Rosetta Stone.
Lynn Massingale, MD
H. Lynn Massingale, MD, FACEP, is Co-Founder and Chairman of Team Health, a multi-billion-dollar corporation now comprised of 20,000 affiliated clinicians delivering care to 3,300 acute and post-acute facilities and physician groups throughout the United States. Serving as CEO from 1979 to 2009, he executed a record-setting merger of emergency physician groups, while simultaneously presiding over impressive organic growth. TeamHealth’s revenues grew from $70 million dollars in 1995 to $1 billion dollars in 2005. The most recent figures show revenue approaching $4 billion dollars.
During that time, TeamHealth has been called one of “America’s Most Trustworthy Companies” by Forbes Magazine, one of the “World’s Most Admired Companies” by Fortune Magazine, and one of the “Great Place to Work in Healthcare” by Becker’s Hospital Review. Among the many honors he has received, “Modern Healthcare” has for the past two years named Dr. Massingale among the “50 Most Influential Physician Executives and Leaders”.
Nathan Every, MD
Nathan Every, MD is General Partner with Frazier Healthcare Partners. A cardiologist by training, Dr. Every previously was associate professor of medicine and the director of the Cardiovascular Outcomes Research Center (CORC) at the University of Washington, where he conducted studies that evaluated the costs and outcomes of new procedures and pharmaceuticals. His findings have been published in dozens of scientific articles including The New England Journal of Medicine, JAMA, and The Lancet.
Since joining Frazier Healthcare Partners in 1999, Dr. Every has led or co-led exited investments in BARRX (acquired by Covidien), Zeltiq, Glaukos, and Packaging Coordinators Inc. (acquired by The Partners Group) and Abode Healthcare.
In addition to HOPCo, Dr. Every currently serves on the boards of Correct Care Solutions, United Derm Partners, Silvergate Pharma, PCI, Leiter’s and Vein Clinics of America.